P38 mitogen activated protein kinase expression and regulation by interleukin-4 in human B cell non-Hodgkin lymphomas

Journal of Hematopathology

Volumn 2, Issue 4, 2009, Pages 195-204

  Ding, Hu ^b   Gabali, Ali M ^a   Jenson, Stephen D ^b   Lim, Megan S ^a   Elenitoba Johnson, Kojo S J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

IL 4; In vitro kinase assay; Isoforms; P p38; P38 MAPK; RT PCR

Indexed keywords

EID: 84869203977     PISSN: None     EISSN: 18655785     Source Type: Journal    
DOI: 10.1007/s12308-009-0049-5     Document Type: Article

References (43)

1. Han J, Lee JD, Bibbs L, Ulevitch RJ (1994) A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808-811
2. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW et al (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739-746
3. Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, Zamanillo D, Hunt T, Nebreda AR (1994) A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78:1027-1037
4. Foltz IN, Lee JC, Young PR, Schrader JW (1997) Hemopoietic growth factors with the exception of interleukin-4 activate the p38 mitogen-activated protein kinase pathway. J Biol Chem 272:3296-3301
5. Kramer RM, Roberts EF, Strifler BA, Johnstone EM (1995) Thrombin induces activation of p38 MAP kinase in human platelets. J Biol Chem 270:27395-27398
6. Raingeaud J, Whitmarsh AJ, Barrett T, Derijard B, Davis RJ (1996) MKK3-and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol Cell Biol 16:1247-1255
7. Han J, Jiang Y, Li Z, Kravchenko VV, Ulevitch RJ (1997) Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 386:296-299
8. Shapiro L, Dinarello CA (1995) Osmotic regulation of cytokine synthesis in vitro. Proc Natl Acad Sci U S A 92:12230-12234
9. Miyazawa K, Mori A, Miyata H, Akahane M, Ajisawa Y, Okudaira H (1998) Regulation of interleukin-1beta-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by p38 mitogen-activated protein kinase. J Biol Chem 273:24832-24838
10. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331
11. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K, Gotoh Y (1997) Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275:90-94
12. Kummer JL, Rao PK, Heidenreich KA (1997) Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogenactivated protein kinase. J Biol Chem 272:20490-20494
13. Jiang Y, Chen C, Li Z, Guo W, Gegner JA, Lin S, Han J (1996) Characterization of the structure and function of a new mitogenactivated protein kinase (p38beta). J Biol Chem 271:17920-17926
14. Stein B, Yang MX, Young DB, Janknecht R, Hunter T, Murray BW, Barbosa MS (1997) p38-2, a novel mitogen-activated protein kinase with distinct properties. J Biol Chem 272:19509-19517
15. Lechner C, Zahalka MA, Giot JF, Moller NP, Ullrich A (1996) ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation. Proc Natl Acad Sci U S A 93:4355-4359
16. Li Z, Jiang Y, Ulevitch RJ, Han J (1996) The primary structure of p38 gamma: a new member of p38 group of MAP kinases. Biochem Biophys Res Commun 228:334-340
17. Wang XS, Diener K, Manthey CL, Wang S, Rosenzweig B, Bray J, Delaney J, Cole CN, Chan-Hui PY, Mantlo N, Lichenstein HS, Zukowski M, Yao Z (1997) Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase. J Biol Chem 272:23668-23674
18. Jiang Y, Gram H, Zhao M, New L, Gu J, Feng L, Di Padova F, Ulevitch RJ, Han J (1997) Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38delta. J Biol Chem 272:30122-30128
19. Lee JC, Kassis S, Kumar S, Badger A, Adams JL (1999) p38 mitogen-activated protein kinase inhibitors-mechanisms and therapeutic potentials. Pharmacol Ther 82:389-397
20. Cohen P (1997) The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell Biol 7:353-361
21. Wilk-Blaszczak MA, Stein B, Xu S, Barbosa MS, Cobb MH, Belardetti F (1998) The mitogen-activated protein kinase p38-2 is necessary for the inhibition of N-type calcium current by bradykinin. J Neurosci 18:112-118
22. Conrad PW, Rust RT, Han J, Millhorn DE, Beitner-Johnson D (1999) Selective activation of p38alpha and p38gamma by hypoxia. Role in regulation of cyclin D1 by hypoxia in PC12 cells. J Biol Chem 274:23570-23576
23. Nemoto S, Xiang J, Huang S, Lin A (1998) Induction of apoptosis by SB202190 through inhibition of p38beta mitogen-activated protein kinase. J Biol Chem 273:16415-16420
24. Enslen H, Brancho DM, Davis RJ (2000) Molecular determinants that mediate selective activation of p38 MAP kinase isoforms. Embo J 19:1301-1311
25. Craxton A, Shu G, Graves JD, Saklatvala J, Krebs EG, Clark EA (1998) p38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes. J Immunol 161:3225-3236
26. Elenitoba-Johnson KS, Jenson SD, Abbott RT, Palais RA, Bohling SD, Lin Z, Tripp S, Shami PJ, Wang LY, Coupland RW, Buckstein R, Perez-Ordonez B, Perkins SL, Dube ID, Lim MS (2003) Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy. Proc Natl Acad Sci U S A 100: 7259-7264
27. Drexler HG (2001) The leukemia-lymphoma cell line factsbook. Academic Press, Boston, pp 263-266
28. Morgan JW, Kouttab N, Ford D, Maizel AL (2000) Vitamin Dmediated gene regulation in phenotypically defined human B cell subpopulations. Endocrinology 141:3225-3234
29. Morrison TB, Weis JJ, Wittwer CT (1998) Quantification of lowcopy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques 24:954-958 960, 962
30. Elenitoba-Johnson KS, Bohling SD, Jenson SD, Lin Z, Monnin KA, Lim MS (2002) Fluorescence PCR quantification of cyclin D1 expression. J Mol Diagnostics 4:90-96
31. Ogasawara T, Yasuyama M, Kawauchi K (2003) Constitutive activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase in B-cell lymphoproliferative disorders. Int J Hematol 77:364-370
32. Lin Z, Crockett DK, Jenson SD, Lim MS, Elenitoba-Johnson KS (2004) Quantitative proteomic and transcriptional analysis of the response to the p38 MAPK inhibitor SB203580 in transformed follicular lymphoma cells. Mol Cell Proteomics 3:820-833
33. Uddin S, Majchrzak B, Woodson J, Arunkumar P, Alsayed Y, Pine R, Young PR, Fish EN, Platanias LC (1999) Activation of the p38 mitogen-activated protein kinase by type I interferons. J Biol Chem 274:30127-30131
34. Vasselon T, Hanlon WA, Wright SD, Detmers PA (2002) Toll-like receptor 2 (TLR2) mediates activation of stress-activated MAP kinase p38. J Leukoc Biol 71:503-510
35. Yang ZO, Hirota Y, Osuga Y, Hamasaki K, Hasegawa A, Tajima T, Hirata T, Koga K, Yoshino O, Harada M, Takemura Y, Nose E, Yano T, Taketani Y (2008) Interleukin-4 stimulates proliferation of endometriotic stromal cells. Am J Pathol 173:463-469
36. Kay NE, Pittner BT (2003) IL-4 biology: impact on normal and leukemic CLL B cells. Leuk Lymphoma 44:897-903
37. Mainou-Fowler T, Proctor SJ, Miller S, Dichnsos AM (2001) Expression and production of interleukin 4 in B-cell chronic lymphocytic leukaemia. Leuk Lymphoma 42:689-698
38. Kay NE, Han L, Bone N, Williams G (2001) Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8+ T cells from B-CLL patients: impact on clonal B-cell apoptosis. Br J Haematol 112:760-767
39. Wery-Zennaro S, Zugaza JL, Letourneur M, Bertoglio J, Pierre J (2000) IL-4 regulation of IL-6 production involves Rac/Cdc42-and p38 MAPK-dependent pathways in keratinocytes. Oncogene 19:1596-1604
40. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J Jr, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO, Staudt LM (2000) Distinct types of diffuse large Bcell lymphoma identified by gene expression profiling. Nature 403:503-511
41. Enslen H, Raingeaud J, Davis RJ (1998) Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J Biol Chem 273:1741-1748
42. Kumar S, McDonnell PC, Gum RJ, Hand AT, Lee JC, Young PR (1997) Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem Biophys Res Commun 235: 533-538
43. Hale KK, Trollinger D, Rihanek M, Manthey CL (1999) Differential expression and activation of p38 mitogen-activated protein kinase alpha, beta, gamma, and delta in inflammatory cell lineages. J Immunol 162:4246-4256